A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety and effectiveness of an investigational drug,
TRN-002 (crofelemer) to relieve the symptoms of diarrhea-predominant irritable bowel syndrome
(IBS).
Phase:
Phase 2
Details
Lead Sponsor:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.